AMN Upgraded by BMO Capital -- Price Target Raised to $43.00
BMO Capital upgraded AMN Healthcare Services to 'Outperform' and raised its price target to $43.00 from $40.00, citing confidence in the company's healthcare staffing market performance. GuruFocus values AMN at $29.53, indicating a 23.6% overvaluation. The stock has a GF Score of 63/100, reflecting moderate financial health. No recent insider trading activity was reported.
How this was made
The 30-second read
Why it matters
The new target could trigger short covering and attract new buyers, but the stock remains overvalued per GF metrics.
Market read
Provides a fresh catalyst for AMN, potentially influencing short-term price action.
What to watch
Growth rating is low (1/10); earnings growth may not meet expectations.
Background
Analyst rating updates can move small- to mid-cap stocks, especially when price targets change.
Ticker impact
BMO Capital upgraded AMN to Outperform and raised the price target to $43 from $40.
likely modest upside as investors price in the higher target
The upgrade reflects improved outlook; no new fundamental data, but the target increase can attract buying.
Market effects
May lift sentiment for healthcare staffing sector.
U.S. healthcare staffing firms could see modest gains.
Limited to U.S. markets; no global ripple.
Counterpoint
The upgrade may be premature given the stock's current overvaluation.
Key entities
- analyst firmBMO Capital
Issued the Outperform rating and $43 price target.
